Clinical Trial Update: High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide [Phase 3]

View source ↗

Summary

Phase 3 trial comparing high-dose intravenous cyclophosphamide with monthly IV cyclophosphamide in systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: COMPLETED